Spire Healthcare Group (LON:SPI) Stock Price Down 18.1% – What’s Next?

Spire Healthcare Group plc (LON:SPI)’s stock price dropped 18.1% on Thursday . The company traded as low as GBX 169 ($2.18) and last traded at GBX 183.80 ($2.37). Approximately 5,375,384 shares traded hands during mid-day trading, an increase of 704% from the average daily volume of 668,624 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 18.1 %

The stock’s fifty day moving average is GBX 229.09 and its two-hundred day moving average is GBX 230.72. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The company has a market capitalization of £738.08 million, a PE ratio of 26.16, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI) last released its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.